Tailored Solutions for Medical Device Success
Medtech Startups Navigate an Uncertain Landscape
Convoluted Regulatory Requirements
Medical device clinical trials are subject to complex regulation and red tape. The approval process is lengthy, confusing, and is never guaranteed.
Competition From Established Players
Established medical device companies have greater brand recognition and existing relationships, making it harder for startups to gain traction and success.
Disinterested Clinical Research Sites
Medical device startups often struggle securing access to healthcare providers. Many hospitals simply aren’t willing to participate in clinical trials using new medical devices.
Prolonged Subject Recruitment
Quickly recruiting patients for medical device clinical trials is close to impossible. Potential patients are often reluctant, have too many options, or are ineligible.
Limited Financial Resources
Medical device startups often lack the financial resources and infrastructure needed to manage their trials, recruit patients, and collect data to analyze.
Latin America Provides Solutions
bioaccess® is your gateway to the untapped potential of conducting cost-effective, fast, and high-quality medical device clinical research studies across Latin America.
We excel in assisting startups with the execution of medical device clinical trials. With a robust presence throughout the region, we are devoted to offering exceptional support and guidance for your project.
Our expertise and far-reaching network enables us to manage trials in multiple countries effectively, ensuring dependable and timely outcomes.
Collaborate with us and experience the certainty that comes from working with a Medtech CRO that is committed to your success.
If You Are Searching For Accelerated Medical Device Clinical Study Results
bioaccess® will quickly and reliably deliver regulatory approval, clinical research site activation, patient recruitment, and trial data.
We connect innovative Medtech startups with top-ranked clinical research sites in Latin America, bringing certainty in:
✔️ Moving to the next phase (an FDA IDE pivotal study)
✔️ Raising funds
✔️ A successful exit
